Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen strengthens IP portfolio

24 Aug 2017 07:00

RNS Number : 8267O
Integumen PLC
24 August 2017
 

Integumen plc

 

("Integumen" or the "Company")

 

Integumen strengthens intellectual property portfolio

 

 

Integumen (LSE: SKIN), the personal health care company developing and commercialising technology and products for the human integumentary system, is pleased to provide an update on its patents and trademarks.

The Company has received:

· a Notice of Allowance ("NOA") for the trademark "Clarogel" in the United States of America, an anti-microbial formulation of usnic acid which is a late stage product designed for blemish control. Since it has received the NOA, Integumen intends to apply for the trademark registration of Clarogel in the United States of America with immediate effect.

· a NOA for its base Visible Youth patent in Canada, for the cosmetic composition for the treatment of skin. These compositions include the combination of Hyaluronic acid and bioactive glass powder which form the basis of Integumen's line of Visible Youth products, a range of cosmeceuticals targeting the anti-ageing market.

· a patent in the United States for the manufacture and sale of TS1, a tongue vacuum cleaner.

Clarogel

Clarogel is an anti-microbial formulation of usnic acid which is a late stage product designed for blemish control. The Company's copper salt of usnic acid is a synthetic derivative of a compound which is found naturally in lichen. It is a permitted cosmetic ingredient in the EU and US with anti-microbial and anti-inflammatory properties. Clarogel was subject to a clinical study in 2011 against a market leading product and demonstrated a greater reduction in inflamed lesions than the comparator after one month of use, and was responsible for significant reductions in sebum excretion*. Integumen is in the process of altering the formulation of Clarogel to improve scent, colour and stability issues evident in the original product.

 

Integumen is the registered owner of a trademark for Clarogel in the EU.

 

* Source: Clearasil Product Sales Analysis, Evaluate Pharma, Evaluate Limited, www.evaluate.com

 

Visible Youth™ 

Visible Youth Consumer and Visible Youth Professional are a consumer and professional range of

'cosmeceuticals' targeting the anti-ageing market. Steeped in evidence-based science, Visible Youth Professional and Consumer skin care products contain the optimal size, purest and most effective Hyaluronic acid molecular fraction and Bioactive Vitryxx®* for deep-penetrating hydration. The unique line of proprietary formulations helps restore the skin's natural supply of HA-water complex, resulting in long-lasting benefits for all skin types.

 

A NOA is a written notification from the U.S. Patent and Trademark Office that a specific trademark has received no opposition from being registered following publication in the Official Gazette. Once a NOA has been received, an applicant is then permitted to file for the registration of the trademark.

TS1

TS1 is a disposable tongue vacuum cleaner for professional use in the dental surgery. The product is a two-component plastic device which has two active sides, a knobby back to massage the tongue and break the biofilm and an open lamella front to clean the tongue by removing plaque. The tongue vacuum cleaner is simply attached to the saliva ejector tube, which is connected to the vacuum unit of the dentist chair. The size of saliva ejectors is standardised and universally found in dental surgeries.

 

 

Declan Service, CEO of Integumen, said:

"These trademarks and patents are highly valuable additions to our intellectual property portfolio and a positive step forward as we seek to generate value through distribution partners or licence agreements."

 

 

Integumen plc

Declan Service, CEO

 

+ 353 (0) 87 770 5506

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Sean Wyndham-Quin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Ltd

(Brokers)

 

Ben Turner/James Pope

 

+44 (0) 20 3621 4120

Cardew Group

Shan Shan Willenbrock

David Roach

 

+44 (0) 20 7930 0777

integumen@cardewgroup.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMGZRVFKGNZM
Date   Source Headline
2nd Oct 20204:51 pmRNSRule 2.9 Announcement - update
2nd Oct 20204:45 pmRNSExercise of Warrants and Total Voting Rights
1st Oct 20205:02 pmRNSForm 8.3 - Integumen Plc
30th Sep 20205:45 pmRNSForm 8.3 - Integumen plc
30th Sep 20207:00 amRNS“First US Integumen COVID19 detection agreement”
28th Sep 20204:46 pmRNSForm 8.3 - Integumen PLC
28th Sep 20204:40 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20204:36 pmRNSPrice Monitoring Extension
25th Sep 20203:36 pmRNSRule 2.9 Announcement - update
25th Sep 20203:35 pmRNSExercise of Warrants and Total Voting Rights
25th Sep 20209:05 amRNSSecond Price Monitoring Extn
25th Sep 20209:00 amRNSPrice Monitoring Extension
25th Sep 20208:47 amRNSForm 8.3 - Integumen plc
25th Sep 20208:18 amRNSForm 8.3 - Integumen Plc
25th Sep 20207:00 amRNSOffer Update
24th Sep 20202:05 pmRNSSecond Price Monitoring Extn
24th Sep 20202:00 pmRNSPrice Monitoring Extension
24th Sep 20201:01 pmRNSResult of AGM
24th Sep 20207:00 amRNSUnveiling of new breath test/dig'l health platform
23rd Sep 20209:05 amRNSSecond Price Monitoring Extn
23rd Sep 20209:00 amRNSPrice Monitoring Extension
22nd Sep 20205:33 pmRNSForm 8.3 - Integumen PLC
21st Sep 20204:43 pmRNSForm 8.3 - Integumen Plc
18th Sep 20205:23 pmRNSIssue of Share Options
18th Sep 20207:00 amRNSInterim Results
17th Sep 20203:23 pmRNSForm 8.3 - Integumen PLC
17th Sep 202012:10 pmRNSForm 8.3 - Integumen PC
16th Sep 20203:40 pmRNSRule 2.9 Announcement - update
16th Sep 20203:35 pmRNSExercise of Warrants and Total Voting Rights
16th Sep 20201:06 pmRNSRule 2.9 Announcement - update
16th Sep 20209:12 amRNSRule 2.9 Announcement - update
15th Sep 20201:40 pmRNSResult of General Meeting
14th Sep 20204:18 pmRNSForm 8.3 - Integumen PLC
14th Sep 202012:30 pmRNSForm 8.3 - Integumen PLC
14th Sep 202010:44 amRNSForm 8 (OPD) - Modern Water plc
14th Sep 202010:42 amRNSForm 8 (OPD) - Modern Water plc
11th Sep 20202:01 pmRNSForm 8 (OPD) - Modern Water plc
11th Sep 20202:00 pmRNSForm 8 (OPD) - Integumen plc
10th Sep 20204:40 pmRNSSecond Price Monitoring Extn
10th Sep 20204:35 pmRNSPrice Monitoring Extension
10th Sep 20202:01 pmRNSRule 2.9 Announcement - update
10th Sep 20202:00 pmRNSExercise of Warrants; Total Voting Rights
9th Sep 20204:44 pmRNSForm 8.3 - Integumen Plc
9th Sep 202012:04 pmRNSReplacement: Form 8.3 - Integumen plc
8th Sep 20204:36 pmRNSRule 2.9 Announcement - update
8th Sep 20204:35 pmRNSExercise of Warrants; Total Voting Rights
8th Sep 20204:21 pmRNSOfferor - Integumen Plc
8th Sep 20204:01 pmRNSForm 8.3 - Offeree - Modern Water Plc
8th Sep 20207:35 amRNSForm 8.3 - Integumen plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.